Enhanced heart failure, mortality and renin activation in female mice with experimental dilated cardiomyopathy
Fan, Tai-Hwang M.
Reed, Guy L.
Gladysheva, Inna P.
AffiliationUniv Arizona, Dept Med, Coll Med Phoenix
MetadataShow full item record
PublisherPUBLIC LIBRARY SCIENCE
CitationEnhanced heart failure, mortality and renin activation in female mice with experimental dilated cardiomyopathy 2017, 12 (12):e0189315 PLOS ONE
Rights© 2017 Tripathi et al. This is an open access article distributed under the terms of the Creative Commons Attribution License.
Collection InformationThis item from the UA Faculty Publications collection is made available by the University of Arizona with support from the University of Arizona Libraries. If you have questions, please contact us at email@example.com.
AbstractDilated cardiomyopathy (DCM) is the major cause of heart failure affecting both women and men. Limited clinical studies show conflicting data in sex-related differences in the progression of dilated cardiomyopathy and heart failure (HF) outcomes. We examined the comparative sex-related progression of cardiomyopathy and the development of HF (at 4, 7, 13 weeks of age) in a well-established, transgenic mouse model of DCM that recapitulates the progressive stages of human HF. By 13 weeks of age, female mice with DCM had more severe left ventricular systolic dysfunction, left ventricular dilation and wall thinning (P< 0.001 for all) than age-matched male mice with DCM. Female mice also had greater lung edema (P< 0.001), cardiac fibrosis (P< 0.01) and pleural effusions, which were not rescued by ovariectomy. By comparison to DCM male mice at 13 weeks, these pathological changes in female mice with DCM, were associated with significant increases in plasma active renin (P< 0.01), angiotensin II (P< 0.01) and aldosterone levels (P< 0.001). In comparison to DCM male mice, DCM female mice also showed differential expression of the natriuretic peptide system with lower corin and higher ANP, BNP and cGMP levels at 13 weeks of age. We conclude, that female mice with experimental DCM have an accelerated progression of cardiomyopathy and HF, which was not corrected by early ovariectomy. These alterations are associated with early renin activation with increased angiotensin II and aldosterone levels, and altered expression of the natriuretic peptide system.
NoteOpen access journal.
VersionFinal published version
SponsorsNIH [HL092750, NS089707, HL115036]; Scientist Development Grant from AHA [14SDG20510068]